骨桥蛋白
生物
结直肠癌
生物标志物
甲基化
小RNA
DNA甲基化
癌症研究
焦测序
拷贝数变化
腺瘤
基因表达
肿瘤科
癌症
基因
生物信息学
遗传学
免疫学
医学
基因组
作者
Margareta Žlajpah,Emanuela Boštjančič,Nina Zidar
出处
期刊:Epigenomics
[Future Medicine]
日期:2020-08-01
卷期号:12 (16): 1389-1403
被引量:5
标识
DOI:10.2217/epi-2020-0032
摘要
Aim: To identify (epi)genetic regulators of osteopontin (OPN, encoded by SPP1 gene) from normal colon mucosa to adenoma, adenoma with early carcinoma and advanced carcinoma. Patients & methods: Biopsy samples of 41 patients with different patohistologic diagnosis were used. Using qPCR, pyrosequencing and statistical analysis, we determined the expression level of osteopontin regulatory miRNAs, its copy number and methylation status. Results & conclusion: We showed that hsa-miR-146a-5p expression is inversely proportional to the expression level of SPP1 and that expression might be also controlled by copy number and methylation. These results suggest that not only expression of SPP1 but also its copy number, methylation status and expression of its regulators might be used as a potential biomarker of colorectal cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI